Transfer Before Support: Why Cardiogenic Shock Patients Referred from Regional Centers Face Higher Device-Related Complications

Transfer Before Support: Why Cardiogenic Shock Patients Referred from Regional Centers Face Higher Device-Related Complications

A large observational study reveals that cardiogenic shock patients receiving temporary mechanical circulatory support at regional referral centers before transfer to hub centers experience significantly higher device-related adverse events and mortality compared to those receiving initial support at hub centers, though this difference may be explained by greater illness severity.
Redefining Post-Cardiac Arrest Care: Two-Year TTM2 Data Confirm No Long-Term Advantage for Targeted Hypothermia

Redefining Post-Cardiac Arrest Care: Two-Year TTM2 Data Confirm No Long-Term Advantage for Targeted Hypothermia

This 2-year follow-up of the TTM2 trial demonstrates that targeted hypothermia at 33°C provides no long-term benefit for functional or cognitive recovery compared to targeted normothermia. The findings emphasize the importance of early fever management and suggest a recovery plateau after six months post-arrest.
Subglottic Suction and Polyurethane Cuffs Fail to Improve Outcomes in Emergency Intubation: Insights from the PreVent 2 Trial

Subglottic Suction and Polyurethane Cuffs Fail to Improve Outcomes in Emergency Intubation: Insights from the PreVent 2 Trial

The PreVent 2 trial demonstrates that specialized endotracheal tubes with subglottic suction and polyurethane cuffs do not significantly reduce ventilator-associated complications or improve 6-month laryngeal, cognitive, or quality-of-life outcomes compared to standard PVC tubes in emergency settings.
Cerebral Oximetry-Guided Treatment Significantly Stabilizes Oxygenation in Extremely Preterm Infants: Results from a Randomized Clinical Trial

Cerebral Oximetry-Guided Treatment Significantly Stabilizes Oxygenation in Extremely Preterm Infants: Results from a Randomized Clinical Trial

A randomized trial involving 100 extremely preterm infants shows that cerebral oximetry-guided treatment using a standardized guideline and NIRS device significantly reduces the burden of cerebral hypoxia and hyperoxia during the first five days of life, potentially improving neuroprotective care.